Neurological symptoms, including paralysis, experienced by Sjögren’s syndrome patients may not be caused by the disease but rather by mental disorders for which psychotherapy may be a better treatment option, a case report suggests. The study, “Systemic Lupus Erythematosus and Sjögren’s Syndrome…
Treatment with interferon-beta (IFN-β) reduces the inflammatory response in immune cells from Sjögren’s syndrome patients, a study reports. The findings suggest that treatment with IFN-β may be a potential way of controlling inflammation in Sjögren’s patients. The study, “…
The average time for a patient to be diagnosed with Sjögren’s syndrome has been reduced from six to less than three years, meeting the “5-Year Breakthrough Goal” established by the Sjögren’s Syndrome Foundation in January 2012. Patients should benefit greatly from this milestone,…
Monoclonal gammopathy, a condition marked by an unusual protein produced in plasma cells and one that can progress to a blood cancer, is evident in patients with Sjögren syndrome and certain other rheumatic diseases, a Chinese study found. Sjögren patients with highly active disease are more likely…
Get regular updates to your inbox.